Profil
Phillip Zamore is the founder of Alnylam Pharmaceuticals, Inc., founded in 2002.
Dr. Zamore is the founder of Voyager Therapeutics, Inc., founded in 2013.
Dr. Zamore currently holds the position of Chairman at RNA Therapeutics Institute.
Dr. Zamore currently holds the position of Professor at UMass Chan Medical School.
Dr. Zamore completed undergraduate and doctorate degrees at Harvard University.
Postes actifs de Phillip Zamore
| Sociétés | Poste | Début |
|---|---|---|
UMass Chan Medical School
UMass Chan Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
RNA Therapeutics Institute | Président | - |
Anciens postes connus de Phillip Zamore
| Sociétés | Poste | Fin |
|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Fondateur | - |
| VOYAGER THERAPEUTICS, INC. | Fondateur | - |
Formation de Phillip Zamore
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
UMass Chan Medical School
UMass Chan Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Voyager Therapeutics, Inc.
Voyager Therapeutics, Inc. BiotechnologyHealth Technology Develops gene therapies for fatal and debilitating diseases of the central nervous system | Health Technology |
RNA Therapeutics Institute |
















